13 November, 2015 by The TZ Newswire Staff Comments Off on The Buffet Backlash: Anger Builds At "Hypocrite" Billionaire Hiding Behind "Folksy" Facade
The Buffet Backlash: Anger Builds At "Hypocrite" Billionaire Hiding Behind "Folksy" Facade
Two days ago in “Billionaire Bitch Fight: Ackman Slams Munger, Buffett For Profiting Off Fat Americans” we highlighted an absurd back-and-forth exchange between Bill Ackman and Buffett’s incorrigible right-hand man Charlie Munger who called Valeant’s business strategy “deeply immoral.”
13 November, 2015 by The TZ Newswire Staff Comments Off on Winds of Change – Major Indexes Short-Term Bearish
Winds of Change – Major Indexes Short-Term Bearish
The most interesting change on the the Scoreboards would be on the S&P 500. It managed to hold on to its Long-Term Trend Model BUY signal for two whole days. This puts the SPX back into a ‘bear market’ to join the Dow Industrials which never relinquished its SELL signal. The short term is looking more bearish as we see Short-Term Trend Model Neutral flags appearing on all but the NDX…
13 November, 2015 by The TZ Newswire Staff Comments Off on Jury finds Ernst & Young liable over investor’s Madoff losses
Jury finds Ernst & Young liable over investor’s Madoff losses
A jury in Seattle sided with FutureSelect Portfolio Management Inc in finding the auditing firm was negligent in its work for funds that funneled money to Madoff. Steven Thomas, FutureSelect’s lawyer, confirmed the verdict.
13 November, 2015 by The TZ Newswire Staff Comments Off on Jury finds Ernst & Young liable over investor’s Madoff losses
Jury finds Ernst & Young liable over investor’s Madoff losses
A jury in Seattle sided with FutureSelect Portfolio Management Inc in finding the auditing firm was negligent in its work for funds that funneled money to Madoff. Steven Thomas, FutureSelect’s lawyer, confirmed the verdict.
13 November, 2015 by The TZ Newswire Staff Comments Off on Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
Pfizer Inc’s (PFE.N) buyout bid for Allergan Plc (AGN.N) has financial markets on edge over a possible new move by the U.S. Treasury Department against tax-inversion deals, but the outlook for any such steps was still unclear on Friday. For months, Treasury has offered no fresh guidance on the inversion issue, leaving tax experts to speculate about what could come next. Inversions typically involve a U.S. multinational buying a smaller foreign rival and relocating to its home country, if only on paper, to escape U.S. taxation.
13 November, 2015 by The TZ Newswire Staff Comments Off on Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules
Pfizer Inc’s (PFE.N) buyout bid for Allergan Plc (AGN.N) has financial markets on edge over a possible new move by the U.S. Treasury Department against tax-inversion deals, but the outlook for any such steps was still unclear on Friday. For months, Treasury has offered no fresh guidance on the inversion issue, leaving tax experts to speculate about what could come next. Inversions typically involve a U.S. multinational buying a smaller foreign rival and relocating to its home country, if only on paper, to escape U.S. taxation.
13 November, 2015 by The TZ Newswire Staff Comments Off on J.C. Penney Reports Solid Sales, but Falls Prey to Broader Retail Collapse
J.C. Penney Reports Solid Sales, but Falls Prey to Broader Retail Collapse
The day’s declines were more about the industry on the whole rather than the discount retailer’s particular results.